Pituitary dysfunction in patients with ANCA associated vasculitis: prevalence, presentation, and outcomes

Pituitary dysfunction in patients with ANCA associated vasculitis: prevalence, presentation, and outcomes

Background: The antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) are rare multisystem autoimmune diseases characterized by inflammatory cell infiltration causing necrosis of small blood vessels. Pituitary involvement in AAV is poorly described. This study aimed to describe the...

Full description

Bibliographic Details
Main Authors:	Chunjia Li, Yu Zou, Xin Lu, Guochun Wang, Xiaoming Shu
Format:	Article
Language:	English
Published:	SAGE Publishing 2020-06-01
Series:	Therapeutic Advances in Chronic Disease
Online Access:	https://doi.org/10.1177/2040622320930636

Similar Items

Endothelial dysfunction of vessels at ANCA-associated systemic vasculitis
by: L. V. Sedaia, et al.
Published: (2015-08-01)

ANCA-associated systemic vasculitis: outcome, vascular dysfunction and the role of anti-TNFa therapy
by: Booth, Anthony Deverell
Published: (2006)

Immunopathogenesis of ANCA-Associated Vasculitis
by: Andreas Kronbichler, et al.
Published: (2020-10-01)

Epidemiology of ANCA associated vasculitis
by: Wenche Koldingsnes, et al.
Published: (2008-01-01)

ANCA-Associated Vasculitis: An Update
by: Salem Almaani, et al.
Published: (2021-04-01)

Clinical features and outcomes of ANCA-associated renal vasculitis
by: Sidy Mohamed Seck, et al.
Published: (2012-01-01)

Post-transplantation Presentation of ANCA-associated Vasculitis: Granulomatosis with Polyangitis
by: M A Shafiee, et al.
Published: (2018-10-01)

Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide?
by: Zachary S. Wallace, et al.
Published: (2019-12-01)

Animal Models of ANCA Associated Vasculitis
by: Lani Shochet, et al.
Published: (2020-04-01)

Individualization of the ANCA associated vasculitis treatment
by: Zbigniew Zdrojewski
Published: (2014-09-01)

Treatment of Renal ANCA-associated Vasculitis
by: Mafalda Teixeira da Costa
Published: (2021)

Granulomatous Inflammation in ANCA-Associated Vasculitis
by: Antje Müller, et al.
Published: (2021-06-01)

Long- term outcome of paediatric patients with ANCA vasculitis
by: Pusey Charles D, et al.
Published: (2011-06-01)

Interstitial Lung Disease with ANCA-associated Vasculitis
by: Yasuhiro Katsumata, et al.
Published: (2015-01-01)

Interstitial Lung Disease with ANCA-associated Vasculitis
by: Yasuhiro Katsumata, et al.
Published: (2015-09-01)

ANCA-associated vasculitis in childhood: recent advances
by: Marta Calatroni, et al.
Published: (2017-05-01)

Why are patients with ANCA-associated vasculitis fatigued?
by: McClean, Andrew
Published: (2016)

Biological therapy in the treatment of ANCA associated vasculitis
by: Smith, Rona Marie
Published: (2016)

Autoreactive B Cells in ANCA-Associated Vasculitis
by: Berti, Alvise
Published: (2021)

ANCA-Associated Vasculitis Clinical Presentation and Clinical Predictors of Relapse in Saudi Arabia
by: Alahmari H, et al.
Published: (2021-07-01)

RECURRENT ANCA-ASSOCIATED VASCULITIS AFTER KIDNEY ALLOTRANSPLANTATION
by: N. F. Frolova, et al.
Published: (2016-03-01)

Circulating B Cells, Plasma Cells, and Treg Associate with ANCA Levels in ANCA-associated Vasculitis
by: Joaquin Manrique, et al.
Published: (2021-02-01)

ANCA-positive vasculitis: Clinical implications of ANCA types and titers
by: Vital Manuel Da Silva Domingues, et al.

Pathogenesis and Diagnosis of Otitis Media with ANCA-Associated Vasculitis
by: Naohiro Yoshida, et al.
Published: (2014-01-01)

Is rituximab effective for induction of remission in ANCA-associated vasculitis?
by: Carmen Rain, et al.
Published: (2015-08-01)

Pauci-Immune Crescentic Glomerulonephritis: An ANCA-Associated Vasculitis
by: Rafeel Syed, et al.
Published: (2015-01-01)

GENETIC SUSCEPTIBILITY TO ANCA-ASSOCIATED VASCULITIS: STATE OF THE ART
by: Francesco eBonatti, et al.
Published: (2014-11-01)

The Contribution of Innate Immunity to the Pathogenesis of ANCA-associated Vasculitis
by: Söderberg, Daniel
Published: (2016)

Dissecting mechanisms of granuloma formation in ANCA-associated vasculitis
by: Henderson, Scott Russell
Published: (2018)

ANCA - associated renal vasculitis - epidemiology, diagnostics and treatment
by: Říhová, Zuzana
Published: (2006)

Alpha-1 Antitrypsin Deficiency Presenting with MPO-ANCA Associated Vasculitis and Aortic Dissection
by: Bram M. Voorzaat, et al.
Published: (2017-01-01)

POS-156 MANAGEMENT AND OUTCOMES OF ANCA ASSOCIATED VASCULITIS AT A TERTIARY HEALTHCARE FACILITY
by: N. MOOLLAN, et al.
Published: (2021-04-01)

PROBLEMS IN THE DIAGNOSIS AND TREATMENT OF ANCA-ASSOCIATED SYSTEMIC VASCULITIS: IN THE FOCUS OF ANCA-NEGATIVE PAUCI-IMMUNE GLOMERULONEPHRITIS
by: T. V. Beketova, et al.
Published: (2016-12-01)

ANCA-associated vasculitis overlaps with systemic sclerosis: a case report and literature review
by: Rui Wu, et al.
Published: (2021-03-01)

Rituximab in ANCA-associated vasculitis presenting with severe acute kidney injury; a case report
by: Macaulay Onuigbo, et al.
Published: (2019-01-01)

THE ONSET OF ANCA-ASSOCIATED SYSTEMIC VASCULITIS MASKING RHEUMATOID ARTHRITIS
by: N. F. Frolova, et al.
Published: (2016-02-01)

Utility of lung ultrasound in ANCA-associated vasculitis with lung involvement.
by: Natalia Buda, et al.
Published: (2019-01-01)

Immunotherapy for ANCA-associated vasculitis during the COVID-19 pandemic
by: Eric J. Gapud, et al.
Published: (2020-08-01)

Hallmark trials in ANCA-associated vasculitis (AAV) for the pediatric rheumatologist
by: Jennifer J. Y. Lee, et al.
Published: (2019-06-01)

Circulating angiopoietin-2 as a biomarker in ANCA-associated vasculitis.
by: Paul A Monach, et al.
Published: (2012-01-01)